206 results
Page 4 of 11
8-K
EX-3.2
g5li9zakjog5 m54i
14 Dec 18
Material Modifications to Rights of Security Holders
7:51am
8-K
EX-99.1
g1f9p
1 Nov 18
Teva Reports Third Quarter 2018 Financial Results
7:02am
8-K
EX-99.1
uidb sy8l
2 Aug 18
Teva Reports Second Quarter 2018 Financial Results
7:00am
10-Q
u73caktx9yyrarffg
3 May 18
Quarterly report
4:08pm
8-K
EX-99.1
w76mxe3m92laf
3 May 18
Teva Reports First Quarter 2018 Financial Results
12:00am
DEFA14A
5lwdcbehik2e3sjh
25 Apr 18
Additional proxy soliciting materials
12:00am
DEF 14A
ucs8928qvjm40
25 Apr 18
Definitive proxy
12:00am
10-K
EX-10.44
p43wlglh8hv bh
12 Feb 18
Annual report
12:00am
10-K
2n360re232 94
12 Feb 18
Annual report
12:00am
10-K
EX-10.22
v01jv1n
12 Feb 18
Annual report
12:00am
10-K
EX-10.20
5ca5br58qavtg80e8 2n
12 Feb 18
Annual report
12:00am
10-K
EX-10.21
qvrvr3hmoio mi35jdqm
12 Feb 18
Annual report
12:00am
10-K
EX-10.31
917ts c3gl9
12 Feb 18
Annual report
12:00am
10-K
EX-10.49
3yyekzp
12 Feb 18
Annual report
12:00am
10-K
EX-10.50
31x0wp9bfj7zs0xefmda
12 Feb 18
Annual report
12:00am
10-K
EX-3.3
c8ua924c7mp5a7ve96n9
12 Feb 18
Annual report
12:00am
424B5
p7t2cfp opb3
18 Jul 16
Prospectus supplement for primary offering
12:00am